ClinicalTrials.Veeva

Menu

Energy Transfer Therapy in Treatment of Medial Gastrocnemius

F

Fundación Universidad Católica de Valencia San Vicente Mártir

Status

Completed

Conditions

Thermography
Sports Physical Therapy
Strain of Gastrocnemius Muscle (Diagnosis)
Diathermy Plate Burn

Treatments

Procedure: TECAR Therapy
Other: Placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT04325750
UCV2017-2018-40

Details and patient eligibility

About

This study develops the effects of Capacitive and Resistive Energy Transfer Therapy (TECAR) on medial gastrocnemius using thermographic cameras, algometry and lunge tests, in a pre-post study with basketball players using a control group to which placebo is applied. (simulated technique) and an intervention group to which the technique is performed. The main objective of the study is to establish whether the TECAR produces physiological and mechanical changes in the subjects that improve muscle recovery.

Enrollment

32 patients

Sex

Male

Ages

16 to 39 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male players
  • Semi-professional players who are currently active
  • Not have suffered a lower limb injury in the last 6 months before the study
  • Not having suffered a rupture of the triceps surae
  • Contain a latent trigger point in the medial gastrocnemius

Exclusion criteria

  • Players suffering from any disease that could alter the study or be contradictory

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

32 participants in 2 patient groups, including a placebo group

Control
Placebo Comparator group
Description:
The simulated mode technique is applied (machine off)
Treatment:
Other: Placebo
TECAR THERAPY
Experimental group
Description:
The intervention will be performed with the T-Care TECAR® therapy machine at the latent trigger points of both gastrocnemius. The professional will apply the therapy with the generator that emits radio frequency signals of 0.5 MHz at a variable power with a maximum of 300W. The frequency to be used will be 500MHz with an intensity of 40% and with direct current.
Treatment:
Procedure: TECAR Therapy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems